Todorov PT - Search Results

1

Monoclonal TCR-redirected tumor cell killing.

Liddy N, Bossi G, Adams KJ, Lissina A, Mahon TM, Hassan NJ, Gavarret J, Bianchi FC, Pumphrey NJ, Ladell K, Gostick E, Sewell AK, Lissin NM, Harwood NE, Molloy PE, Li Y, Cameron BJ, Sami M, Baston EE, Todorov PT, Paston SJ, Dennis RE, Harper JV, Dunn SM, Ashfield R, Johnson A, McGrath Y, Plesa G, June CH, Kalos M, Price DA, Vuidepot A, Williams DD, Sutton DH, Jakobsen BK. Liddy N, et al. Among authors: todorov pt. Nat Med. 2012 Jun;18(6):980-7. doi: 10.1038/nm.2764. Nat Med. 2012. PMID: 22561687

2

Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.

Sami M, Rizkallah PJ, Dunn S, Molloy P, Moysey R, Vuidepot A, Baston E, Todorov P, Li Y, Gao F, Boulter JM, Jakobsen BK. Sami M, et al. Protein Eng Des Sel. 2007 Aug;20(8):397-403. doi: 10.1093/protein/gzm033. Epub 2007 Jul 20. Protein Eng Des Sel. 2007. PMID: 17644531

3

High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.

Moysey RK, Li Y, Paston SJ, Baston EE, Sami MS, Cameron BJ, Gavarret J, Todorov P, Vuidepot A, Dunn SM, Pumphrey NJ, Adams KJ, Yuan F, Dennis RE, Sutton DH, Johnson AD, Brewer JE, Ashfield R, Lissin NM, Jakobsen BK. Moysey RK, et al. Protein Cell. 2010 Dec;1(12):1118-27. doi: 10.1007/s13238-010-0144-5. Epub 2011 Jan 8. Protein Cell. 2010. PMID: 21213105 Free PMC article.

4

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.

Raman MC, Rizkallah PJ, Simmons R, Donnellan Z, Dukes J, Bossi G, Le Provost GS, Todorov P, Baston E, Hickman E, Mahon T, Hassan N, Vuidepot A, Sami M, Cole DK, Jakobsen BK. Raman MC, et al. Sci Rep. 2016 Jan 13;6:18851. doi: 10.1038/srep18851. Sci Rep. 2016. PMID: 26758806 Free PMC article.

5

Stable, soluble T-cell receptor molecules for crystallization and therapeutics.

Boulter JM, Glick M, Todorov PT, Baston E, Sami M, Rizkallah P, Jakobsen BK. Boulter JM, et al. Among authors: todorov pt. Protein Eng. 2003 Sep;16(9):707-11. doi: 10.1093/protein/gzg087. Protein Eng. 2003. PMID: 14560057

6

Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode.

Cole DK, Sami M, Scott DR, Rizkallah PJ, Borbulevych OY, Todorov PT, Moysey RK, Jakobsen BK, Boulter JM, Baker BM, Yi Li. Cole DK, et al. Among authors: todorov pt. Front Immunol. 2013 Jun 26;4:168. doi: 10.3389/fimmu.2013.00168. eCollection 2013. Front Immunol. 2013. PMID: 23805144 Free PMC article.

7

Characterization of a cancer cachectic factor.

Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Todorov P, et al. Nature. 1996 Feb 22;379(6567):739-42. doi: 10.1038/379739a0. Nature. 1996. PMID: 8602222

8

Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.

McDevitt TM, Todorov PT, Beck SA, Khan SH, Tisdale MJ. McDevitt TM, et al. Among authors: todorov pt. Cancer Res. 1995 Apr 1;55(7):1458-63. Cancer Res. 1995. PMID: 7882353

9

Induction of muscle protein degradation and weight loss by a tumor product.

Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ. Todorov PT, et al. Cancer Res. 1996 Mar 15;56(6):1256-61. Cancer Res. 1996. PMID: 8640810

10

Catabolic factors in cancer cachexia.

Tisdale MJ, McDevitt TM, Todorov PT, Cariuk P. Tisdale MJ, et al. Among authors: todorov pt. In Vivo. 1996 Mar-Apr;10(2):131-6. In Vivo. 1996. PMID: 8744791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page